Amy Billman is a skilled computational biologist currently employed at Recursion since November 2025. Previously, Billman served as a biocomputational scientist at Quell Therapeutics from September 2023 to October 2025, and as an investigator and senior scientist at GSK from October 2016 to May 2023, focusing on machine learning applications in cytometry and automation of bioinformatic analyses for cell and gene therapy. Academic achievements include a Ph.D. in Retrovirology, a Master’s Degree in Biomedical Research, and a Bachelor’s Degree in Biomedical Sciences, all from Imperial College London, complemented by an International Baccalaureate from the International School of Geneva.
This person is not in any teams
This person is not in any offices